Disabled-2 (Dab2) Inhibits Wnt/β-catenin Signalling by Binding LRP6 and Promoting Its Internalization Through Clathrin

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2012 Apr 12

PMID 22491013

Citations 47

Authors

Yong Jiang

Xi He

Philip H Howe

Affiliations

Soon will be listed here.

Abstract

Canonical Wnt signalling requires caveolin-dependent internalization of low-density lipoprotein receptor-related protein 6 (LRP6). Here we report that the tumour suppressor and endocytic adaptor disabled-2 (Dab2), previously described as an inhibitor of Wnt/β-catenin signalling, selectively recruits LRP6 to the clathrin-dependent endocytic route, thereby sequestering it from caveolin-mediated endocytosis. Wnt stimulation induces the casein kinase 2 (CK2)-dependent phosphorylation of LRP6 at S1579, promoting its binding to Dab2 and internalization with clathrin. LRP6 receptor mutant (S1579A), deficient in CK2-mediated phosphorylation and Dab2 binding, fails to associate with clathrin, and thus escapes the inhibitory effects of Dab2 on Wnt/β-catenin signalling. Our data suggest that the S1579 site of LRP6 is a negative regulatory point during LRP6-mediated dorsoventral patterning in zebrafish and in allograft mouse tumour models. We conclude that the tumour suppressor functions of Dab2 involve modulation of canonical Wnt signalling by regulating the endocytic fate of the LRP6 receptor.

Citing Articles

Multi-omics characterization of the monkeypox virus infection.

Huang Y, Bergant V, Grass V, Emslander Q, Hamad M, Hubel P Nat Commun. 2024; 15(1):6778.

PMID: 39117661 PMC: 11310467. DOI: 10.1038/s41467-024-51074-6.

Dab2 (Disabled-2), an adaptor protein, regulates self-renewal of hair follicle stem cells.

Roy S, Mehta D, Paradkar A, Chovatiya G, Waghmare S Commun Biol. 2024; 7(1):525.

PMID: 38702433 PMC: 11068889. DOI: 10.1038/s42003-024-06047-2.

Perturbation of intestinal stem cell homeostasis and radiation enteritis recovery via dietary titanium dioxide nanoparticles.

Zhang L, He Y, Dong L, Liu C, Su L, Guo R Cell Prolif. 2023; 56(8):e13427.

PMID: 36798041 PMC: 10392070. DOI: 10.1111/cpr.13427.

Disabled-2 (): A Key Regulator of Anti- and Pro-Tumorigenic Pathways.

Price Z, Lokman N, Yoshihara M, Kajiyama H, Oehler M, Ricciardelli C Int J Mol Sci. 2023; 24(1).

PMID: 36614139 PMC: 9821069. DOI: 10.3390/ijms24010696.

Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through -catenin/MDR1 signaling to sustain chemoresistance.

Ghatak S, Hascall V, Karamanos N, Markwald R, Misra S Front Oncol. 2022; 12:906260.

PMID: 36330477 PMC: 9623568. DOI: 10.3389/fonc.2022.906260.

References

MacDonald B, Tamai K, He X . Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009; 17(1):9-26. PMC: 2861485. DOI: 10.1016/j.devcel.2009.06.016. View

Doherty G, McMahon H . Mechanisms of endocytosis. Annu Rev Biochem. 2009; 78:857-902. DOI: 10.1146/annurev.biochem.78.081307.110540. View

Xu X, Yang W, Jackowski S, Rock C . Cloning of a novel phosphoprotein regulated by colony-stimulating factor 1 shares a domain with the Drosophila disabled gene product. J Biol Chem. 1995; 270(23):14184-91. DOI: 10.1074/jbc.270.23.14184. View

Sato A, Yamamoto H, Sakane H, Koyama H, Kikuchi A . Wnt5a regulates distinct signalling pathways by binding to Frizzled2. EMBO J. 2009; 29(1):41-54. PMC: 2808370. DOI: 10.1038/emboj.2009.322. View

Prunier C, Hocevar B, Howe P . Wnt signaling: physiology and pathology. Growth Factors. 2004; 22(3):141-50. DOI: 10.1080/08977190410001720860. View

Zhoul J, Hernandez G, Tu S, Huang C, Tseng C, Hsieh J . The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer. Cancer Res. 2005; 65(21):9906-13. DOI: 10.1158/0008-5472.CAN-05-1481. View

Morris S, Arden S, Roberts R, Kendrick-Jones J, Cooper J, Luzio J . Myosin VI binds to and localises with Dab2, potentially linking receptor-mediated endocytosis and the actin cytoskeleton. Traffic. 2002; 3(5):331-41. DOI: 10.1034/j.1600-0854.2002.30503.x. View

Blitzer J, Nusse R . A critical role for endocytosis in Wnt signaling. BMC Cell Biol. 2006; 7:28. PMC: 1534015. DOI: 10.1186/1471-2121-7-28. View

Pan W, Choi S, Wang H, Qin Y, Volpicelli-Daley L, Swan L . Wnt3a-mediated formation of phosphatidylinositol 4,5-bisphosphate regulates LRP6 phosphorylation. Science. 2008; 321(5894):1350-3. PMC: 2532521. DOI: 10.1126/science.1160741. View

10.

Pinna L . Protein kinase CK2: a challenge to canons. J Cell Sci. 2002; 115(Pt 20):3873-8. DOI: 10.1242/jcs.00074. View

11.

Tseng C, Huang C, Tseng C, Lin M, Hsieh J, Tseng C . Induction of disabled-2 gene during megakaryocyte differentiation of k562 cells. Biochem Biophys Res Commun. 2001; 285(1):129-35. DOI: 10.1006/bbrc.2001.5133. View

12.

Bilic J, Huang Y, Davidson G, Zimmermann T, Cruciat C, Bienz M . Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science. 2007; 316(5831):1619-22. DOI: 10.1126/science.1137065. View

13.

Zeng X, Tamai K, Doble B, Li S, Huang H, Habas R . A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature. 2005; 438(7069):873-7. PMC: 2100418. DOI: 10.1038/nature04185. View

14.

Clevers H . Wnt/beta-catenin signaling in development and disease. Cell. 2006; 127(3):469-80. DOI: 10.1016/j.cell.2006.10.018. View

15.

Sun W, Smith E, Cohen C, Sheng Z, Xu X . Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells. Oncogene. 2000; 19(42):4847-54. DOI: 10.1038/sj.onc.1203853. View

16.

Smith E, Capo-chichi C, He J, Smedberg J, Yang D, Prowse A . Disabled-2 mediates c-Fos suppression and the cell growth regulatory activity of retinoic acid in embryonic carcinoma cells. J Biol Chem. 2001; 276(50):47303-10. DOI: 10.1074/jbc.M106158200. View

17.

Tamai K, Zeng X, Liu C, Zhang X, Harada Y, Chang Z . A mechanism for Wnt coreceptor activation. Mol Cell. 2004; 13(1):149-56. DOI: 10.1016/s1097-2765(03)00484-2. View

18.

Taelman V, Dobrowolski R, Plouhinec J, Fuentealba L, Vorwald P, Gumper I . Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell. 2010; 143(7):1136-48. PMC: 3022472. DOI: 10.1016/j.cell.2010.11.034. View

19.

Jiang Y, Prunier C, Howe P . The inhibitory effects of Disabled-2 (Dab2) on Wnt signaling are mediated through Axin. Oncogene. 2007; 27(13):1865-75. PMC: 2810718. DOI: 10.1038/sj.onc.1210829. View

20.

Fuerer C, Nusse R, Ten Berge D . Wnt signalling in development and disease. Max Delbrück Center for Molecular Medicine meeting on Wnt signaling in Development and Disease. EMBO Rep. 2008; 9(2):134-8. PMC: 2246409. DOI: 10.1038/sj.embor.7401159. View